tility of fecal calprotectin in patients with Crohn's disease
Not Applicable
- Conditions
- Crohn's disease
- Registration Number
- JPRN-UMIN000013363
- Lead Sponsor
- ational Defense Medical College Hospital second internal medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Not provided
Exclusion Criteria
The duration of each examinations is more than two weeks. The therapy changed during each examinations. Disease activity changed during each examinations.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method